Biological therapy in elderly patients with acute myeloid leukemia.

Giulia Ciotti Giovanni MarconiAlessandra SperottoMaria B GianniniMichele GottardiGiovanni Martinelli

Published in: Expert opinion on biological therapy (2023)

Overall, this therapeutic armamentarium will constitute the basis for multimodal and personalized combinations that, in the idea of precision medicine, will enormously benefit elderly AML patients.

Keyphrases

acute myeloid leukemia
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
middle aged
patient reported outcomes